BioPharma

17 November, 2026 | Tuesday | Analysis

Sold, Closed or Mothballed: 19 APAC Drug Manufacturing Sites That Changed Hands or Shut in 2026

Openings in this region arrive with ceremony. There is a groundbreaking, a ribbon, a minister and a press release with a capacity figure in the headline. Exits arrive as a line in an exchange filing, a statemen...

Lab

17 November, 2026 | Tuesday | News

Eppendorf and Nova Biomedical Integrate Sampling and Analysis to Automate Bioprocess Control

Eppendorf and Nova Biomedical® collaborate to integrate the Eppendorf Bioprocess Autosampler with the BioProfile FLEX2 cell culture analyzer. The integration enables automated at-line analysis of critical p...

BioTech

17 November, 2026 | Tuesday | Analysis

The 10 New Drugs Japan Expects to Sell Most: Peak-Sales Forecasts From Every 2026 NHI Listing Round

On 13 November, 16 new medicines joined Japan's National Health Insurance (NHI) price list. It was the last of the seven listing rounds Japan now runs each year, and it arrived in the quiet weeks before the gov...

Contract Services

04 November, 2026 | Wednesday | News

Lonza to Acquire Five US CDMO Sites from Merck KGaA to Double Manufacturing Footprint

Lonza acquires five CDMO manufacturing sites and approximately 1,100 highly skilled employees, more than doubling its US footprint to nine CDMO sites with a US workforce of more than 6,000 employees. Transac...

Consumer Health

17 November, 2026 | Tuesday | News

Takeda and Zuellig Pharma Partner to Expand Medicine Access Across Three Southeast Asian Markets

Takeda and Zuellig Pharma announced a strategic regional collaboration to enhance sustainable patient access to innovative medicines and healthcare solutions across Malaysia, Indonesia and the Philippines. Effe...

Medtech

17 November, 2026 | Tuesday | News

Thailand Approves YONDELIS for Advanced Soft Tissue Sarcoma

Independent biopharmaceutical company Specialised Therapeutics announced that the Thailand Food and Drug Administration approved YONDELIS® (trabectedin) on 24 July 2026 for the treatment of adult patie...

Cell & Gene

12 November, 2026 | Thursday | Expert Insight

Scaling Personalised Therapies Across APAC Starts With Supply Chain Readiness

As cell and gene therapies advance across Asia-Pacific, supply chains must connect complex manufacturing processes with individual patients’ treatment schedules. In this BioPharma APAC interview, Mervin S...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close